These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7509966)
1. A new experimental model of epilepsy based on the intraventricular injection of endothelin. Gross PM; Weaver DF J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S282-7. PubMed ID: 7509966 [TBL] [Abstract][Full Text] [Related]
2. Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation? Gross PM; Beninger RJ; Shaver SW; Wainman DS; Espinosa FJ; Weaver DF Exp Brain Res; 1993; 95(3):397-408. PubMed ID: 8224065 [TBL] [Abstract][Full Text] [Related]
3. Dose-related potent brain stimulation by the neuropeptide endothelin-1 after intraventricular administration in conscious rats. Chew BH; Weaver DF; Gross PM Pharmacol Biochem Behav; 1995 May; 51(1):37-47. PubMed ID: 7617731 [TBL] [Abstract][Full Text] [Related]
4. NMDA-mediated metabolic activation of the cerebellar cortex in behaving rats by the neuropeptide endothelin-1. Chew BH; Weaver DF; Balaban CD; Gross PM Brain Res; 1994 Jun; 647(2):345-52. PubMed ID: 7922510 [TBL] [Abstract][Full Text] [Related]
5. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Gross PM; Weaver DF; Ho LT; Pang JJ; Edvinsson L Neuropharmacology; 1994 Oct; 33(10):1155-66. PubMed ID: 7862251 [TBL] [Abstract][Full Text] [Related]
6. Cerebral hypermetabolism produced by intraventricular endothelin-1 in rats: inhibition by nimodipine. Gross PM; Wainman DS; Espinosa FJ; Nag S; Weaver DF Neuropeptides; 1992 Apr; 21(4):211-23. PubMed ID: 1325610 [TBL] [Abstract][Full Text] [Related]
7. Intraventricular endothelin-1 uncouples the blood flow: metabolism relationship in periventricular structures of the rat brain: involvement of L-type calcium channels. Gross PM; Zochodne DW; Wainman DS; Ho LT; Espinosa FJ; Weaver DF Neuropeptides; 1992 Jul; 22(3):155-65. PubMed ID: 1331845 [TBL] [Abstract][Full Text] [Related]
9. Differentiated metabolic stimulation of rat pituitary lobes by peripheral and central endothelin-1. Gross PM; Wainman DS; Espinosa FJ Endocrinology; 1991 Aug; 129(2):1110-2. PubMed ID: 1855455 [TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
11. Potent metabolic stimulation of septal gray and cerebral white matter in vivo by intraventricular endothelin and nitric oxide. Gross PM; Weaver DF; Wainman DS; Chew BH; Espinosa FJ; Nag S Biochem Biophys Res Commun; 1993 Feb; 190(3):975-81. PubMed ID: 8439346 [TBL] [Abstract][Full Text] [Related]
12. Behavioural, autonomic and endocrine responses associated with C-fos expression in the forebrain and brainstem after intracerebroventricular infusions of endothelins. Zhu B; Herbert J Neuroscience; 1996 Apr; 71(4):1049-62. PubMed ID: 8684609 [TBL] [Abstract][Full Text] [Related]
13. Role of endothelin receptor subtypes in the behavioral effects of the intracerebroventricular administration of endothelin-1 in conscious rats. Nagasaka J; Tsuji M; Takeda H; Matsumiya T Pharmacol Biochem Behav; 1999 Sep; 64(1):171-6. PubMed ID: 10495013 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists. Sharkey J; Ritchie IM; Butcher SP; Kelly JS Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171 [TBL] [Abstract][Full Text] [Related]
15. A combined cobalt and C-14 2-deoxyglucose approach to antiepileptic drug assessment. Krenz NR; Cooper RM Int J Neurosci; 1996 Jul; 86(1-2):55-66. PubMed ID: 8828060 [TBL] [Abstract][Full Text] [Related]
16. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P. Dermon CR; Tzagournissakis M; Savaki HE Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat. Grasby P; Sharp T; Moorman J; Grahame-Smith D Eur J Pharmacol; 1993 Jan; 230(1):41-6. PubMed ID: 8094054 [TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat. Mitchell EA; Pratt JA Brain Res; 1991 Jan; 538(2):289-94. PubMed ID: 1826459 [TBL] [Abstract][Full Text] [Related]
19. Intraventricular administration of gabapentin in the rat increases flurothyl seizure threshold. Oommen J; Kraus AC; Fisher RS Neurosci Lett; 2007 May; 417(3):308-11. PubMed ID: 17363166 [TBL] [Abstract][Full Text] [Related]
20. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP. Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]